Closing Bell: Medicenna Therapeutics Corp down on Tuesday (MDNA)

In market activity today, Medicenna Therapeutics Corp opened at $2.30 and closed at $2.16. Intraday prices ranged from $2.15 to $2.30.

Share prices decreased -4.42% from the previous day's close of $2.26.

Today across North America, the TSX Composite closed -2.18% at 22227.63, the S&P 500 closed -3.00% at 5186.33, the Dow Jones Industrial Average closed -2.60% at 38703.27 and the Nasdaq Composite closed -3.43% at 16200.08.

Medicenna Therapeutics Corp has listed on the Toronto Stock Exchange (TSX) under the ticker MDNA.

Trading volume was 108,502 on 212 total trades, while having an average volume of 103,075 in the last five days.

The TSX overall saw 3,772 price advancers against 1,443 declines and 86 unchanged.

During the prior 52 weeks, MDNA.TO has traded as high as $2.98 (June 03,2024) and low as $0.22 (November 01,2023). Moreover, in the last 52 weeks, Medicenna Therapeutics Corp's shares have risen 285.71%, while they have risen 414.29% year-to-date.

Following today's trading, Medicenna Therapeutics Corp has a market capitalization of $172.74 million on a float of 76,433 shares outstanding. Its annual EPS is $-0.23.

Medicenna Therapeutics Corp is a TSX Biotechnology company headquartered in Toronto, CAN.

Based on 2.00 analysts, Medicenna Therapeutics Corp gets an average recommendation of "Strong Buy" according to Zacks. From those 2 analysts, 2 have buy ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..